Viridian Therapeutics Inc
LSE:0K1R
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Shareholder Yield
Current shareholder yield for 
0K1R is
.
Dividends, buybacks and debt paydown, as one yield.
Create a free account · No card needed
Create a free account · No card needed
Create a free account · No card needed
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0K1R Price
Viridian Therapeutics Inc
| Average Annual Return | 11.35% |
| Standard Deviation of Annual Returns | 36.25% |
| Max Drawdown | -74% |
| Market Capitalization | 3.5B USD |
| Shares Outstanding | 215 675 039 513 |
| Percentage of Shares Shorted |
N/A
|
0K1R Return Decomposition
Main factors of price return
Stock Splits
0K1R's latest stock split occurred on Nov 13, 2020
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, 0K1R traded at 1.8481 per share. Afterward, the share price was about 12.5793.
The adjusted shares began trading on Nov 13, 2020. This was the only stock split in 0K1R's history.
